Sulindac is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by H.j. Harkins Company, Inc.. The primary component is Sulindac.
| Product ID | 52959-195_91275e67-c112-480e-b4c9-1de9f51ac081 |
| NDC | 52959-195 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Sulindac |
| Generic Name | Sulindac |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 1990-04-03 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA071795 |
| Labeler Name | H.J. Harkins Company, Inc. |
| Substance Name | SULINDAC |
| Active Ingredient Strength | 200 mg/1 |
| Pharm Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
| Marketing Start Date | 1990-04-03 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA071795 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1990-04-03 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA071795 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1990-04-03 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA071795 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1990-04-03 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA071795 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1990-04-03 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA071795 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1990-04-03 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA071795 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1990-04-03 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA071795 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1990-04-03 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| SULINDAC | 200 mg/1 |
| SPL SET ID: | 145a1b4a-16ef-4f29-b47e-f52c47514c9a |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| PHarm Class EPC | |
| NUI Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0378-0427 | Sulindac | sulindac |
| 0378-0531 | Sulindac | sulindac |
| 0591-5660 | Sulindac | Sulindac |
| 0591-5661 | Sulindac | Sulindac |
| 0904-6216 | Sulindac | Sulindac |
| 0904-6217 | Sulindac | Sulindac |
| 23155-005 | Sulindac | Sulindac |
| 23155-006 | Sulindac | Sulindac |
| 24658-770 | SULINDAC | SULINDAC |
| 24658-771 | SULINDAC | SULINDAC |
| 33261-100 | Sulindac | Sulindac |
| 42806-011 | SULINDAC | SULINDAC |
| 42806-018 | SULINDAC | SULINDAC |
| 50090-0528 | Sulindac | Sulindac |
| 50090-0529 | SULINDAC | SULINDAC |
| 50090-2093 | SULINDAC | sulindac |
| 50090-4976 | Sulindac | Sulindac |
| 51079-667 | Sulindac | sulindac |
| 52959-195 | Sulindac | Sulindac |
| 53489-478 | SULINDAC | sulindac |
| 53489-479 | SULINDAC | sulindac |
| 68151-2871 | Sulindac | Sulindac |
| 68151-2872 | Sulindac | Sulindac |
| 71335-0535 | SULINDAC | SULINDAC |
| 71335-0413 | SULINDAC | SULINDAC |
| 53808-0302 | SULINDAC | SULINDAC |
| 53808-0303 | Sulindac | Sulindac |
| 54738-902 | Sulindac | Sulindac |
| 53808-0814 | Sulindac | Sulindac |
| 53808-0799 | Sulindac | Sulindac |
| 54738-903 | Sulindac | Sulindac |
| 55289-930 | Sulindac | Sulindac |
| 55700-682 | SULINDAC | SULINDAC |
| 60429-697 | SULINDAC | SULINDAC |
| 60429-698 | SULINDAC | SULINDAC |
| 63629-3208 | Sulindac | Sulindac |
| 70934-550 | Sulindac | Sulindac |